Helping two global pharma companies uncover a winning position for launch of a new drug
Escalent has done some great work for me and my team over the past years...great moderating skills and research reporting.
Escalent has done some great work for me and my team over the past years...great moderating skills and research reporting.
Two global pharma companies joined forces to launch a new prescription medicine for treatment of a mental health condition. The clients understood how competitive the landscape is for mental health treatment products and needed Escalent’s help to identify market needs for four audiences: patients, caregivers, psychiatrists and primary care doctors. They also needed help developing, assessing and finalizing the strongest position for this new treatment.
Escalent facilitated in-person workshops with multidisciplinary client teams from both companies. We then conducted several rounds of qualitative research in and outside the US. We used pre-research activities—patient chart pulls for doctors and photo stories for patients—as well as storytelling to gain a comprehensive understanding of the impact of mental conditions. Then we overlaid the unmet needs of the market with the new treatment’s benefits and tested four market insights. By blending this qualitative research with the clients’ previous quantitative research, we identified one very strong insight that was used to develop and test the elements of the product positioning story.
We successfully identified one specific need and crafted a meaningful and durable positioning recommendation to senior management. The clients were extremely pleased with how well the positioning was constructed—it was believable, important and achievable. The clients launched the product using our recommendation as the backbone of the positioning and continue to use the positioning two years later. Global sales are approaching half a billion dollars and the clients’ brand strength has improved year over year.
Read this blog to learn why Escalent, C Space and Hall & Partners believe brands must give as much as they seek to get.
Latest Cogent Syndicated report reveals advisors consider external wholesaler meetings more effective. To optimize advisor engagement, asset managers need to work to maximize the number and effectiveness of combined interactions
Your captain has turned on the fasten seatbelt sign. Travel & Tourism navigates bumpy skies.
Escalent’s technology experts explore how understanding the origins of generative artificial intelligence (AI) can help tech companies effectively strategize on integrating generative AI into their business and offerings for maximum customer impact
Uncertainty shocks are here to stay. Brace for change with market intelligence, flexible staff augmentation and foresight.
The metaverse and emerging technology are shaping the next evolution in streaming services as consumers look for more immersive entertainment.
Along with solid investments returns, institutional investors are also seeking practical and insightful market perspectives. Cogent Syndicated's annual review of the US institutional market reveals the undercurrent of unmet needs among institutional investors offers a unique opportunity for wealth management firms to demonstrate their capabilities.
A new report from Cogent Syndicated reveals that Netflix and Amazon Prime Video are widely popular video streaming sites among financial advisors, with more than two-thirds of financial advisors subscribing to each platform.
A new report from Cogent Syndicated finds that while growth has stalled for advisor's use of model portfolios, SMA allocations are forecasted to grow significantly over the next two years.
